Jinlin Song

Vice President
Jinlin Song

Los Angeles


Ph.D., applied mathematics, University of Southern California; M.S., statistics, University of Southern California; B.A., applied mathematics, Shanghai Jiaotong University

Summary of Experience

Dr. Song specializes in health economics and outcomes research (HEOR). She has extensive experience applying advanced statistical techniques to solve complex real-world research questions in health care, frequently using data from clinical trials, electronic medical records, administrative claims, medical chart reviews, surveys, and disease registries. Dr. Song has conducted indirect treatment comparisons such as network meta-analyses and matching-adjusted indirect comparisons, as well as economic modeling such as cost-effectiveness analyses and budget impact analyses. Her research covers a broad range of therapeutic areas – including endocrinology, oncology, hematology, nephrology, infectious diseases, autoimmune diseases, and rare genetic diseases – and involves assessing burden of illness, treatment patterns, and drug adherence; performing systematic literature reviews; and conducting studies evaluating real-world economic and clinical outcomes. Dr. Song has developed strategic plans for real-world evidence generation and supported the launch of multiple novel oncology products, including targeted therapies, immuno-oncology agents, and gene therapies. Her work has been widely published in peer-reviewed journals and presented at clinical and economic research conferences.

Selected Publishing